GCIA
TSVT

Gabelli & Co Investment Advisers’s 2seventy bio TSVT Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-192,450
Closed -$951K – 278
2025
Q1 		$951K Buy
+192,450
New +$611K 0.14% 105

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gabelli & Co Investment Advisers's TSVT Position: Q2 2025 in Review

Gabelli & Co Investment Advisers sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 192,450 shares — an estimated $951K sold.

Gabelli & Co Investment Advisers first reported a position in TSVT in Q1 2025 and held it in 1 quarter. The position peaked at $951K in Q1 2025. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Gabelli & Co Investment Advisers reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 192,450 2seventy bio shares in Q2 2025, an estimated $951K.
  • Gabelli & Co Investment Advisers first reported a position in 2seventy bio in Q1 2025 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's 2seventy bio position peaked at $951K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.